Biotech policy, regulations & bioethics form the foundational framework that ensures responsible innovation in biotechnology. As advances in genetic editing, synthetic biology, and personalized medicine accelerate, regulatory agencies and global policymakers face the challenge of balancing innovation with public safety and ethical integrity. This field encompasses the formulation of guidelines governing clinical trials, intellectual property, environmental release, and cross-border biotech trade. Bioethics plays a critical role in addressing concerns surrounding genome editing, data privacy, consent in biobanking, and equity in access to biotech products. Biotech policy, regulations & bioethics ensure transparency, accountability, and societal trust while facilitating global collaboration. A well-regulated landscape not only protects public interests but also accelerates adoption of life-enhancing technologies in healthcare, agriculture, and the environment.
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico